Finance

Lists
BLAU3:BVMF
Blau Farmaceutica SA
12,51 R$
0,00%
(0,00) 1D
14 áƒáƒ„áƒą, 17:04:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for BLAU3...
Open
12,33 R$
High
12,83 R$
Low
12,01 R$
Mkt. cap
2,92 მლრდ.
Avg. vol.
292,48 ათ.
Volume
418,50 ათ.
Dividend
5,55%
Quarterly dividend
0,17 R$
Ex-dividend date
19 დეკ. 2025
P/E ratio
12,48
52-wk high
12,89 R$
52-wk low
8,22 R$
EPS
1,00 R$
Shares outstanding
233,21 მლნ.
No. of employees
2 ათ.
Open
12,33 R$
High
12,83 R$
Low
12,01 R$
Mkt. cap
2,92 მლრდ.
Avg. vol.
292,48 ათ.
Volume
418,50 ათ.
Dividend
5,55%
Quarterly dividend
0,17 R$
Ex-dividend date
19 დეკ. 2025
P/E ratio
12,48
52-wk high
12,89 R$
52-wk low
8,22 R$
EPS
1,00 R$
Shares outstanding
233,21 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Stock Titan
Stock Titan
·
13 წუთის წინ
A distiller and ingredient producer plans to bring three businesses under Sempreon
U.S. News - Money
U.S. News - Money
·
45 წუთის წინ
S&P 500's March to 8,000 Hinges on 'Very, Very Strong' Third Quarter
CNBC
CNBC
·
15 წუთის წინ
Nasdaq futures fall as tech shares drop on fears of AI overspending; traders await more U.S. data
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
A Staggering 84% of S&P 500 Stocks Are Now in Correction Territory, and History Says This Foreshadows Disaster for Wall Street
About Blau Farmaceutica SA
CEOმარსელო როდოლჀო ჰან
Employees1,9 ათ.
Founded1987
Headquarters-
Sector-
Websiteblau.com
Last report
12 აგვ. 2026
Fiscal period
Q2 2026
0,31 R$ / 0,33 R$
-8,01%miss
Revenue / Est. (BRL)
486,60 მლნ. / 497,66 მლნ.
-2,22%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
áƒĄáƒ”áƒ„. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
475,20 მლნ.
389,36 მლნ.
434,97 მლნ.
486,60 მლნ.
Cost of goods sold
282,46 მლნ.
235,99 მლნ.
254,72 მლნ.
274,60 მლნ.
Cost of revenue
282,46 მლნ.
235,99 მლნ.
254,72 მლნ.
274,60 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,17 მლნ.
100,07 მლნ.
94,55 მლნ.
100,58 მლნ.
Operating expense
101,15 მლნ.
104,83 მლნ.
95,01 მლნ.
128,66 მლნ.
Total operating expenses
383,61 მლნ.
340,82 მლნ.
349,73 მლნ.
403,25 მლნ.
Operating income
91,59 მლნ.
48,54 მლნ.
85,24 მლნ.
83,34 მლნ.
Other non operating income
-
-2,58 მლნ.
-2,87 მლნ.
-
EBT including unusual items
138,33 მლნ.
44,19 მლნ.
52,20 მლნ.
65,45 მლნ.
EBT excluding unusual items
138,33 მლნ.
44,19 მლნ.
52,20 მლნ.
65,45 მლნ.
Income tax expense
32,81 მლნ.
6,81 მლნ.
15,92 მლნ.
9,91 მლნ.
Effective tax rate
23,72%
15,41%
30,49%
15,15%
Other operating expenses
10,98 მლნ.
4,76 მლნ.
461,00 ათ.
28,08 მლნ.
Net income
104,42 მლნ.
36,25 მლნ.
39,77 მლნ.
53,39 მლნ.
Net profit margin
21,97%
9,31%
9,14%
10,97%
Earnings per share
0,53
-
0,17
0,31
Interest and investment income
106,52 მლნ.
9,95 მლნ.
12,94 მლნ.
18,65 მლნ.
Interest expense
-59,77 მლნ.
-22,99 მლნ.
-21,35 მლნ.
-36,54 მლნ.
Net interest expenses
46,75 მლნ.
-13,04 მლნ.
-8,41 მლნ.
-17,89 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
103,32 მლნ.
62,47 მლნ.
99,62 მლნ.
98,53 მლნ.
Gain or loss from assets sale
-
50,02 მლნ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები